Profund Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,221
Closed -$108K 995
2025
Q1
$108K Sell
10,221
-865
-8% -$13.7K ﹤0.01% 946
2024
Q4
$188K Sell
11,086
-1,728
-13% -$32.5K 0.01% 1021
2024
Q3
$297K Sell
12,814
-1,495
-10% -$32K 0.01% 802
2024
Q2
$348K Sell
14,309
-9,915
-41% -$301K 0.01% 634
2024
Q1
$818K Buy
24,224
+5,800
+31% +$206K 0.03% 408
2023
Q4
$581K Sell
18,424
-3,874
-17% -$92.1K 0.03% 472
2023
Q3
$570K Sell
22,298
-6,310
-22% -$194K 0.03% 430
2023
Q2
$820K Sell
28,608
-887
-3% -$24.1K 0.04% 368
2023
Q1
$707K Buy
+29,495
New +$529K 0.04% 397

Other funds holding ARCT